Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

7VPK

Cryo-EM structure of the human ATP13A2 (SPM-bound E2P state)

Summary for 7VPK
Entry DOI10.2210/pdb7vpk/pdb
EMDB information32068
DescriptorPolyamine-transporting ATPase 13A2, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, MAGNESIUM ION, ... (5 entities in total)
Functional Keywordsatp13a2, park9, p-type atpase, membrane protein
Biological sourceHomo sapiens (Human)
Total number of polymer chains1
Total formula weight130030.44
Authors
Tomita, A.,Yamashita, K.,Nishizawa, T.,Nureki, O. (deposition date: 2021-10-17, release date: 2021-12-29, Last modification date: 2024-10-16)
Primary citationTomita, A.,Daiho, T.,Kusakizako, T.,Yamashita, K.,Ogasawara, S.,Murata, T.,Nishizawa, T.,Nureki, O.
Cryo-EM reveals mechanistic insights into lipid-facilitated polyamine export by human ATP13A2.
Mol.Cell, 81:4799-4809.e5, 2021
Cited by
PubMed Abstract: The cytoplasmic polyamine maintains cellular homeostasis by chelating toxic metal cations, regulating transcriptional activity, and protecting DNA. ATP13A2 was identified as a lysosomal polyamine exporter responsible for polyamine release into the cytosol, and its dysfunction is associated with Alzheimer's disease and other neural degradation diseases. ATP13A2 belongs to the P5 subfamily of the P-type ATPase family, but its mechanisms remain unknown. Here, we report the cryoelectron microscopy (cryo-EM) structures of human ATP13A2 under four different conditions, revealing the structural coupling between the polyamine binding and the dephosphorylation. Polyamine is bound at the luminal tunnel and recognized through numerous electrostatic and π-cation interactions, explaining its broad specificity. The unique N-terminal domain is anchored to the lipid membrane to stabilize the E2P conformation, thereby accelerating the E1P-to-E2P transition. These findings reveal the distinct mechanism of P5B ATPases, thereby paving the way for neuroprotective therapy by activating ATP13A2.
PubMed: 34798056
DOI: 10.1016/j.molcel.2021.11.001
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (3.92 Å)
Structure validation

227561

PDB entries from 2024-11-20

PDB statisticsPDBj update infoContact PDBjnumon